Novyra Pharmachem Board Meeting Set for Q1 Results
Bansisons Tea Industries Ltd 路 Intimation 路 14 Aug 2026, 5:30 am
Novyra Pharmachem Board Meeting Set for Q1 Results Novyra Pharmachem Limited (BSE: 519353) has scheduled a Board of Directors meeting on 14th Aug'26. The primary agenda is to consider and approve the unaudited financial results for the first quarter ending 30th Jun'26. The results will be accompanied by the Auditor's Limited Review Report. The company was formerly known as Bansisons Tea Industries Ltd.
Original exchange filing (PDF)
More announcements from Bansisons Tea Industries Ltd
- Unaudited Financial Results for the quarter ended September 30, 2026 路 02 Nov 2026
- Unaudited financial results for the quarter ended September 30, 2026 路 02 Nov 2026
- Novyra Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... 路 02 Nov 2026
- Intimation under Reg 30 路 24 Sept 2026
- Reg 30 路 22 Aug 2026
- Quarterly Results June 30, 2026 路 14 Aug 2026
- Quarterly Results June 30, 2026 路 14 Aug 2026
- Change of Website 路 04 Aug 2026
